ABOUT GlobeImmune NEWSROOM CAREERS CONTACT US INVESTORS PLATFORM CANCER INFECTIOUS DISEASE GlobeImmune | INVESTORS | Press Releases Press Releases Print Receive E-mail Alerts Click here to receive press releases by email from the company. Press Releases Date Title 08/28/2017 Globeimmune Provides Update on Recent Clinical Trial Developments 03/23/2017 GlobeImmune Announces Majority Stock Sale 11/17/2016 GlobeImmune Announces Updates 07/05/2016 GlobeImmune Announces Delisting and Deregistration of Common Stock 05/12/2016 GlobeImmune Announces Updates and Financial Results for First Quarter 2016 03/16/2016 GlobeImmune Announces Updates and Financial Results for Full Year 2015 11/13/2015 GlobeImmune Announces Third Quarter 2015 Results and Corporate Highlights 08/14/2015 GlobeImmune Announces Second Quarter 2015 Results and Corporate Highlights 08/13/2015 GlobeImmune Engages Cantor Fitzgerald as Financial Advisor to Assist With Evaluation of Strategic Options 08/04/2015 Celgene Exercises Early Option to Exclusively License GI-6207, a Novel Cancer Immunotherapy 08/04/2015 UPDATE – Celgene Exercises Early Option to Exclusively License GI-6207, a Novel Cancer Immunotherapy 06/10/2015 GlobeImmune Announces Evaluation of Strategic Alternatives and Corporate Restructuring 05/27/2015 GlobeImmune Announces Top Line Results From GS-4774 Phase 2 Trial in Virally-Suppressed Chronic HBV Patients 05/14/2015 GlobeImmune Announces First Quarter 2015 Results and Corporate Highlights 04/22/2015 GlobeImmune Announces Opening of Randomized Phase 2 Chordoma Trial at National Cancer Institute 03/17/2015 GlobeImmune Announces Program Updates and Financial Results for Full Year 2014 03/02/2015 GlobeImmune to Present at the 27th Annual ROTH Conference 02/03/2015 GlobeImmune to Present at the 17th Annual BIO CEO & Investor Conference 11/12/2014 GlobeImmune Announces Third Quarter 2014 Financial Results 10/17/2014 Updated Chordoma Data From Phase 1 Study of GI-6301 Presented at 2014 Connective Tissue Oncology Society (CTOS) Annual Meeting 09/30/2014 GlobeImmune to Present at the 13th Annual BioInvestor Forum 09/18/2014 GlobeImmune to Present at the 21st Annual NewsMakers in the Biotechnology Industry Investment Conference 09/03/2014 GlobeImmune to Present at the Aegis Capital Corp. 2014 Healthcare Conference 07/01/2014 GlobeImmune Announces Pricing of Initial Public Offering Investors Stock Information SEC Filings Press Releases Events Corporate Governance Investor FAQs SITE MAP » CONTACT US » CURRENT EMPLOYEES / INTRANET » Copyright © GlobeImmune Inc. All Rights Reserved. Corporate Headquarters 1450 Infinite Drive Louisville, Colorado 80027 Phone: 720.667.2300